Bgi Genomics Co.,Ltd.’s Net Profit Dropped 37.6% in First Quarter of 2022

Bgi Genomics Co.,Ltd. (深圳华大基因股份有限公司) (300676.SZ) reported a net profit of 331.8 million yuan in the first quarter of 2022, down 37.6% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 8.5% year-on-year.

At the end of the reporting period, it had 13.4 billion yuan in total assets and 4 billion yuan in total liabilities, with a liability-to-asset ratio of 29.8%.